Is Alzheimer's disease a mitochondrial disorder?

被引:31
|
作者
Cash, AD [1 ]
Perry, G [1 ]
Ogawa, O [1 ]
Raina, AK [1 ]
Zhu, XW [1 ]
Smith, MA [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
来源
NEUROSCIENTIST | 2002年 / 8卷 / 05期
关键词
Alzheimer's disease; amyloid-beta; antioxidants; free radicals; mitochondria; neurodegeneration;
D O I
10.1177/107385802236968
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cell bodies of neurons at risk of death in Alzheimer's disease (AD) have increased lipid peroxidation, nitration, free carbonyls, and nucleic acid oxidation. These oxidative changes occur in all vulnerable neurons and are reduced in neurons that contain neurofibrillary pathology. In this review, the authors provide a summary of recent work that demonstrates key abnormalities that may play a part in initiating and promoting neuronal oxidative damage. Mitochondrial abnormalities are clearly involved as a source of reactive oxygen species that culminates in perikaryal oxidative damage. However, because mitochondria in AD do not exhibit striking evidence of oxidative damage, as would be expected if they produced free radicals directly, the authors suspected that abnormal mitochondria are responsible for supplying a key reactant, that once in the cytoplasm, releases radicals. Because abnormal mitochondria, H2O2 and redox-active iron are juxtaposed in the same AD neuron, it has all the markings of a "radical factory." The proximal causes of mitochondrial abnormalities likely involve reentry into the cell cycle, where organellokinesis and proliferation results in an increase of mitochondria and intermediately differentiated cells, with a consequent increase in turnover. Supporting this, the authors have considerable in vivo and in vitro evidence for mitotic disturbances in AD.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [41] Mitochondrial biology in Alzheimer's disease pathogenesis
    Galindo, Maria F.
    Ikuta, Ichiro
    Zhu, Xiongwei
    Casadesus, Gemma
    Jordan, Joaquin
    JOURNAL OF NEUROCHEMISTRY, 2010, 114 (04) : 933 - 945
  • [42] Mitochondrial DNA mutations in Alzheimer's disease
    Hutchin, TP
    Heath, PR
    Pearson, RCA
    Sinclair, AJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (02) : 221 - 225
  • [43] The Alzheimer's Disease Mitochondrial Cascade Hypothesis
    Swerdlow, Russell H.
    Burns, Jeffrey M.
    Khan, Shaharyar M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S265 - S279
  • [44] Mitochondrial DNA variation in Alzheimer’s disease
    Aleksandra Maruszak
    Krzysztof Safranow
    Katarzyna Gawęda-Walerych
    Tomasz Gabryelewicz
    Jeffrey A. Canter
    Maria Barcikowska
    Cezary Żekanowski
    Pharmacological Reports, 2011, 63 : 1278 - 1278
  • [45] Metabolomics and mitochondrial dysfunction in Alzheimer’s disease
    Dong Hee Kim
    Jeong-An Gim
    Dahye Yoon
    Suhkmann Kim
    Heui-Soo Kim
    Genes & Genomics, 2017, 39 : 295 - 300
  • [46] Role of mitochondrial dysfunction in Alzheimer's disease
    Castellani, R
    Hirai, K
    Aliev, G
    Drew, KL
    Nunomura, A
    Takeda, A
    Cash, AD
    Obrenovich, ME
    Perry, G
    Smith, MA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 357 - 360
  • [47] Mitochondrial DNA mutations in Alzheimer's Disease
    Hamblet, N
    Ragland, B
    Ali, M
    Castora, F
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A310 - A310
  • [48] The mitochondrial and β-amyloid relationship in Alzheimer's disease
    Young, Kisha
    Iyer, Shilpa
    Bennett, James
    MITOCHONDRION, 2010, 10 (02) : 215 - 215
  • [49] Mitochondrial oxidant signalling in Alzheimer's disease
    Vina, Jose
    Lloret, Ana
    Valles, Soraya L.
    Borras, Consuelo
    Badia, Mari-Carmen
    Pallardo, Federico V.
    Sastre, Juan
    Alonso, Maria-Dolores
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (02) : 175 - 181
  • [50] Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease
    Chris Cadonic
    Mohammad Golam Sabbir
    Benedict C. Albensi
    Molecular Neurobiology, 2016, 53 : 6078 - 6090